Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Specialist training in infectious diseases in Europe.
Salmanton-García J, Guerra Maio A, Stahl JP, Barra E, Jensen-Fangel S, Torti C, Kraef C, Miró JM, Verbon A, Cornely OA, Beeching NJ; European Union of Medical Specialists (UEMS) Infectious Diseases Section and the Trainee Association (TAE) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Salmanton-García J, et al. Among authors: jensen fangel s. Clin Microbiol Infect. 2024 Dec 24:S1198-743X(24)00614-1. doi: 10.1016/j.cmi.2024.12.026. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39725078 Free article.
Impact of elexacaftor/tezacaftor/ivacaftor on utilization of routine therapies in cystic fibrosis: Danish nationwide register study.
Råket HK, Jensen CB, Wang JN, Pressler T, Olesen HV, Skov M, Jensen-Fangel S, Petersen J, Jimenez-Solem E; TransformCF study group. Råket HK, et al. Among authors: jensen fangel s. J Cyst Fibros. 2024 Nov 23:S1569-1993(24)01813-7. doi: 10.1016/j.jcf.2024.11.004. Online ahead of print. J Cyst Fibros. 2024. PMID: 39581783 Free article.
Close monitoring and early intervention: management principles for cystic fibrosis in Denmark.
Qvist T, Nielsen BU, Olesen HV, Mathiesen IHM, Faurholt-Jepsen D, Katzenstein TL, Helweg-Larsen J, Rönsholt F, Jeppesen M, Olsen MF, Buchvald FF, Nielsen KG, Jensen-Fangel S, Pressler T, Skov M. Qvist T, et al. Among authors: jensen fangel s. APMIS. 2024 Apr;132(4):223-235. doi: 10.1111/apm.13375. Epub 2024 Jan 24. APMIS. 2024. PMID: 38267398 Review.
Real-world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis.
Bryrup T, Faurholt-Jepsen D, Pressler T, Henriksen EH, Leo-Hansen C, Nielsen BU, Højte C, Mathiesen IHM, Katzenstein TL, Jeppesen M, Jensen-Fangel S, Olesen HV, Skov M, Qvist T, Olsen MF; TransformCF Study Group. Bryrup T, et al. Among authors: jensen fangel s. APMIS. 2024 Oct;132(10):728-733. doi: 10.1111/apm.13453. Epub 2024 Aug 2. APMIS. 2024. PMID: 39092470
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.
Qvist T, Gilljam M, Jönsson B, Taylor-Robinson D, Jensen-Fangel S, Wang M, Svahn A, Kötz K, Hansson L, Hollsing A, Hansen CR, Finstad PL, Pressler T, Høiby N, Katzenstein TL; Scandinavian Cystic Fibrosis Study Consortium (SCFSC). Qvist T, et al. J Cyst Fibros. 2015 Jan;14(1):46-52. doi: 10.1016/j.jcf.2014.08.002. Epub 2014 Aug 30. J Cyst Fibros. 2015. PMID: 25178871 Free PMC article.
Lung function improvement on triple modulators: high-resolution, nationwide data from the Danish Cystic Fibrosis Cohort.
Leo-Hansen C, Faurholt-Jepsen D, Qvist T, Højte C, Nielsen BU, Bryrup T, Henriksen EH, Katzenstein T, Skov M, Mathiesen IHM, Jeppesen M, Jensen-Fangel S, Olesen HV, Buchvald FF, Nielsen KG, Jimenez-Solem E, Ritz C, Pressler T, Olsen MF; TransformCF Study Group. Leo-Hansen C, et al. Among authors: jensen fangel s. ERJ Open Res. 2024 Dec 9;10(6):00339-2024. doi: 10.1183/23120541.00339-2024. eCollection 2024 Nov. ERJ Open Res. 2024. PMID: 39655171 Free PMC article.
96 results